Novo Nordisk said Monday it has launched its popular obesity drug Wegovy in China, the world’s second-largest pharmaceuticals market where it estimates more than 180 million people live with obesity.
Wegovy is being made available to Chinese patients five months after its approval in the country. Novo will sell the medicine ...
Robert F. Kennedy Jr. would have broad power as HHS secretary to strip vaccine makers' protections against lawsuits ...
U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...
Novo Nordisk said on Monday it has launched its popular obesity drug Wegovy in China, the world's second-largest ...
Novo Nordisk said on Monday it has launched its popular obesity drug Wegovy in China, the world's second-largest pharmaceuticals market.
Wegovy's approval by China's NMPA targets individuals with a BMI of 30+ with related health issues; initial supply will be ...
Doctors say they have not seen anything like this since the emergence of statins to lower cholesterol. But do we know enough ...
Novo Nordisk and Eli Lilly are facing scores of personal injury claims for allegedly failing to warn patients about side ...
Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcoholism, a new study suggests. Researchers explain why ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback